Loading clinical trials...
Loading clinical trials...
Phase III, Single Centre, Double Blind, Randomised Study Evaluating the Consistency of Three Lots of Henogen's New Adjuvanted Hepatitis B Vaccine, When Given at 0, 1 Month Schedule in Healthy Volunteers Aged 18 Years to 40 Years.
Conditions
Interventions
Adjuvanted Hepatitis B vaccine Lot 1
Adjuvanted Hepatitis B vaccine Lot 2
+1 more
Locations
1
Czechia
Vaccination and Travel Medicine Centre Poliklinika II
Hradec Králové, Czechia
Start Date
January 1, 2008
Primary Completion Date
April 1, 2008
Completion Date
April 1, 2008
Last Updated
August 25, 2008
NCT07024641
NCT06671093
NCT07275554
NCT03826433
NCT06885710
NCT06947499
Lead Sponsor
Henogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions